Transcript segment

Baric Transcribed Interview (Redacted), p.13 · baric_ti:utt:00045

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric

Oh, we started working with Gilead in 2016 on a work on identifying broad-spectrum, small molecule inhibitors against the coronavirus family.

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

I knew you were going to ask that question. At some point the neuron will fire.
2026-04-10 09:00 Christina Salazar open

So you said that was January 4th?
2026-04-10 09:00 Ralph S. Baric open

Yeah, yeah. It's in the testimony, I think, in the House. Yeah.
2026-04-10 09:00 Christina Salazar open

And had you already been working with DC.Scheduling@LexitasLegal.com Gilead?
2026-04-10 09:00 Ralph S. Baric

Oh, we started working with Gilead in 2016 on a work on identifying broad-spectrum, small molecule inhibitors against the coronavirus family.
2026-04-10 09:00 Christina Salazar open

Okay. And I'm going to jump around, based on our conversation, so I'm going to go ahead and ask this now.
2026-04-10 09:00 Ralph S. Baric open

Sure.
2026-04-10 09:00 Christina Salazar open

Did you serve as an expert consultant for Gilead in terms of their patent dispute against AMMS?
2026-04-10 09:00 Ralph S. Baric open

No.